MedPath

Which iron supplementation regime for pregnant women provides the best maternal and infant outcomes?

Not Applicable
Completed
Conditions
Anaemia in pregnancy
Iron deficiency in pregnancy
Low birth weight
infant growth and development
maternal mental health
Public Health - Epidemiology
Reproductive Health and Childbirth - Antenatal care
Registration Number
ACTRN12610000944033
Lead Sponsor
niversity of Melbourne
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
1250
Inclusion Criteria

healthy pregnant women 16 weeks gestation or less

Exclusion Criteria

complicated pregnancies (e.g. twins, diabetes, other medical conditions), or Hb<=8.0

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
birth weight[Within 72 hours of birth]
Secondary Outcome Measures
NameTimeMethod
Maternal Haemoglobin<br>This will be assessed at the field site by blood analysis using a HemoCue 201+ (HemoCue AB, Angelholm, Sweden).[32 weeks gestation];Maternal ferritin<br>This will be assessed by blood analysis using a sandwich immunoenzymatic assay.[32 weeks gestation];Infant cognitive development<br>This will be assessed by trained psychologists using Bayley Scales of Infant Development III (BSID).[6 months of age];infant height[6 months of age];infant haemoglobin<br>This will be assessed at the field site by blood analysis using a HemoCue 201+ (HemoCue AB, Angelholm, Sweden).[6 months of age]
© Copyright 2025. All Rights Reserved by MedPath